{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T06:27:03Z","timestamp":1768976823049,"version":"3.49.0"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>To evaluate the long-term incidence of hypercoagulable complications in young patients with retinal vein occlusions and negative workups compared with matched controls.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A retrospective cohort study was conducted using the TriNetX Analytics Network. Patients aged 18 to 50 with newly diagnosed retinal vein occlusion and no history of hypertension, glaucoma, thrombophilia, or recent oral contraceptive use were compared with age-matched controls. Propensity score matching was performed to balance baseline demographics and comorbidities. Primary outcomes included the cumulative incidence and risk ratio (RR) of deep vein thrombosis, pulmonary embolism, cerebral infarction, anticoagulant use, composite embolic events, myocardial infarctions and composite cardiovascular events over 1, 3, and 5 years. A secondary validation cohort was performed using controls diagnosed with astigmatism.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      After propensity score matching, 2,731 patients were included in each cohort. Patients with retinal vein occlusion had significantly higher rates of venous thromboembolism, cerebral infarction, anticoagulation use, and composite embolic outcomes at 1, 3, and 5 years (all\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.0001). No significant differences were observed in myocardial infarctions or composite cardiovascular event outcomes.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Young patients with retinal vein occlusion and no identifiable vascular or hypercoagulable risk factors are at significantly increased risk for venous thrombosis and stroke, but not myocardial infarction.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/iae.0000000000004700","type":"journal-article","created":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T13:02:20Z","timestamp":1761224540000},"page":"229-239","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["SYSTEMIC THROMBOEMBOLIC OUTCOMES IN YOUNG PATIENTS AFTER RETINAL VEIN OCCLUSIONS"],"prefix":"10.1097","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1257-0476","authenticated-orcid":false,"given":"Charles","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida;"},{"name":"Department of Ophthalmology, Ross Eye Institute, SUNY Buffalo, Buffalo, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Ayoubi","sequence":"additional","affiliation":[{"name":"Miller School of Medicine, University of Miami, Miami, Florida; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan B.","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Byers Eye Institute, Stanford University School of Medicine, Stanford, California."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georges","family":"AbouKasm","sequence":"additional","affiliation":[{"name":"Miller School of Medicine, University of Miami, Miami, Florida; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neel R.","family":"Sonik","sequence":"additional","affiliation":[{"name":"Miller School of Medicine, University of Miami, Miami, Florida; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joaquin","family":"Sosa-Lockwood","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Audina","family":"Berrocal","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida;"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20260120","doi-asserted-by":"crossref","first-page":"010427","DOI":"10.7189\/jogh.09.010427","article-title":"Global epidemiology of retinal vein occlusion: a systematic review and meta-analysis of prevalence, incidence, and risk factors","volume":"9","author":"Song","year":"2019","journal-title":"J Glob Health"},{"key":"R2-20260120","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1111\/j.1538-7836.2010.03909.x","article-title":"Retinal vein thrombosis: pathogenesis and management","volume":"8","author":"Rehak","year":"2010","journal-title":"J Thromb Haemost"},{"key":"R3-20260120","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/00063198-200309000-00008","article-title":"Hypercoagulable states and central retinal vein occlusion","volume":"9","author":"Lahey","year":"2003","journal-title":"Curr Opin Pulm Med"},{"key":"R4-20260120","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1111\/ijcp.12390","article-title":"Risk factors associated with retinal vein occlusion","volume":"68","author":"Martinez","year":"2014","journal-title":"Int J Clin Pract"},{"key":"R5-20260120","doi-asserted-by":"crossref","first-page":"1180234","DOI":"10.3389\/fmed.2023.1180234","article-title":"Central retinal vein occlusion in young population: risk factors and outcomes","volume":"10","author":"Berguig","year":"2023","journal-title":"Front Med (Lausanne)"},{"key":"R6-20260120","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1007\/s40123-022-00534-7","article-title":"Clinical features of central retinal vein occlusion in young patients","volume":"11","author":"Zhang","year":"2022","journal-title":"Ophthalmol Ther"},{"issue":"suppl 1","key":"R7-20260120","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.4103\/sja.SJA_543_18","article-title":"The STROBE guidelines","volume":"13","author":"Cuschieri","year":"2019","journal-title":"Saudi J Anaesth"},{"key":"R8-20260120","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1038\/s41433-024-03008-1","article-title":"Systematic review of clinical practice guidelines for the diagnosis and management of retinal vein occlusion","volume":"38","author":"Galvez-Olortegui","year":"2024","journal-title":"Eye (Lond)"},{"key":"R9-20260120","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.21037\/atm-22-2730","article-title":"A narrative review on the association of high intraocular pressure and glaucoma in patients with retinal vein occlusion","volume":"10","author":"Jabbehdari","year":"2022","journal-title":"Ann Transl Med"},{"key":"R10-20260120","doi-asserted-by":"crossref","first-page":"79","DOI":"10.4103\/0974-1208.112389","article-title":"Oral contraceptive pills: a risk factor for retinal vascular occlusion in in-vitro fertilization patients","volume":"6","author":"Aggarwal","year":"2013","journal-title":"J Hum Reprod Sci"},{"key":"R11-20260120","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1055\/s-0038-1642037","article-title":"Hypercoagulable states and thrombophilias: risks relating to recurrent venous thromboembolism","volume":"35","author":"Rybstein","year":"2018","journal-title":"Semin Intervent Radiol"},{"key":"R12-20260120","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1378\/chest.13-1635","article-title":"Development of a novel composite stroke and bleeding risk score in patients with atrial fibrillation: the AMADEUS study","volume":"144","author":"Lip","year":"2013","journal-title":"Chest"},{"key":"R13-20260120","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1097\/HJH.0000000000002057","article-title":"Hypertension and multiple cardiovascular risk factors increase the risk for retinal vein occlusions: results from the gutenberg retinal vein occlusion study","volume":"37","author":"Ponto","year":"2019","journal-title":"J Hypertens"},{"key":"R14-20260120","first-page":"120","article-title":"Risk factors for venous and arterial thrombosis","volume":"9","author":"Previtali","year":"2011","journal-title":"Blood Transfus"},{"key":"R15-20260120","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.oret.2021.03.009","article-title":"Hypercoagulability testing and hypercoagulable disorders in young central retinal vein occlusion patients","volume":"6","author":"Tauqeer","year":"2022","journal-title":"Ophthalmol Retina"},{"key":"R16-20260120","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.1111\/jth.15068","article-title":"Inherited and acquired thrombophilia in adults with retinal vascular occlusion: a systematic review and meta-analysis","volume":"18","author":"Romiti","year":"2020","journal-title":"J Thromb Haemost"},{"key":"R17-20260120","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1160\/TH07-11-0658","article-title":"The prevalence of activated protein C (APC) resistance and factor V Leiden is significantly higher in patients with retinal vein occlusion without general risk factors. Case-control study and meta-analysis","volume":"99","author":"Rehak","year":"2008","journal-title":"Thromb Haemost"},{"key":"R18-20260120","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1160\/TH04-10-0659","article-title":"Increased prevalence of factor V Leiden in patients with retinal vein occlusion and under 60 years of age","volume":"94","author":"Arsene","year":"2005","journal-title":"Thromb Haemost"},{"key":"R19-20260120","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1055\/s-0038-1648808","article-title":"Hypercoagulability and high lipoprotein(a) levels in patients with central retinal vein occlusion","volume":"72","author":"Bandello","year":"1994","journal-title":"Thromb Haemost"},{"key":"R20-20260120","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/aos.13228","article-title":"Elevated lipoprotein (a) levels are an independent risk factor for retinal vein occlusion","volume":"95","author":"Kuhli-Hattenbach","year":"2017","journal-title":"Acta Ophthalmol"},{"key":"R21-20260120","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1442-9071.2006.01212.x","article-title":"Is elevated level of soluble endothelial protein C receptor a new risk factor for retinal vein occlusion?","volume":"34","author":"Gumus","year":"2006","journal-title":"Clin Exp Ophthalmol"},{"key":"R22-20260120","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/s41433-022-02038-x","article-title":"Retinal vein occlusion is associated with stroke independent of underlying cardiovascular disease","volume":"37","author":"Bakhoum","year":"2023","journal-title":"Eye (Lond)"},{"key":"R23-20260120","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ajo.2023.08.022","article-title":"Risk of stroke, myocardial infarction, deep vein thrombosis, pulmonary embolism, and death after retinal vein occlusion","volume":"257","author":"Wai","year":"2024","journal-title":"Am J Ophthalmol"},{"key":"R24-20260120","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1161\/CIRCRESAHA.116.308447","article-title":"Cryptogenic stroke: research and practice","volume":"120","author":"Yaghi","year":"2017","journal-title":"Circ Res"},{"key":"R25-20260120","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1177\/2396987317703210","article-title":"Searching for explanations for cryptogenic stroke in the young: revealing the triggers, causes, and outcome (SECRETO): rationale and design","volume":"2","author":"Putaala","year":"2017","journal-title":"Eur Stroke J"},{"key":"R26-20260120","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/s41598-020-79499-1","article-title":"Associating cryptogenic ischemic stroke in the young with cardiovascular risk factor phenotypes","volume":"11","author":"Dardick","year":"2021","journal-title":"Sci Rep"},{"key":"R27-20260120","doi-asserted-by":"crossref","first-page":"80","DOI":"10.4103\/2277-9175.127993","article-title":"Factor V Leiden does not have a role in cryptogenic ischemic stroke among Iranian young adults","volume":"3","author":"Kheradmand","year":"2014","journal-title":"Adv Biomed Res"},{"key":"R28-20260120","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1093\/eurheartj\/ehr488","article-title":"Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish atrial fibrillation cohort study","volume":"33","author":"Friberg","year":"2012","journal-title":"Eur Heart J"},{"key":"R29-20260120","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1056\/NEJMoa1802686","article-title":"Rivaroxaban for stroke prevention after embolic stroke of undetermined source","volume":"378","author":"Hart","year":"2018","journal-title":"N Engl J Med"},{"key":"R30-20260120","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1056\/NEJMoa1813959","article-title":"Dabigatran for prevention of stroke after embolic stroke of undetermined source","volume":"380","author":"Diener","year":"2019","journal-title":"N Engl J Med"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000004700","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T17:00:27Z","timestamp":1768928427000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000004700"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0000000000004700","relation":{},"ISSN":["0275-004X","1539-2864"],"issn-type":[{"value":"0275-004X","type":"print"},{"value":"1539-2864","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2]]}}}